Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Tuesday, December 09, 2014 | ENZO Biochem Reports Strong Fiscal First Quarter Results Operating Earnings Growth In Life Sciences and Clinical Labs |
Wednesday, December 03, 2014 | ENZO Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday, December 10, 2014 at 8:30 am e.t. |
Thursday, October 09, 2014 | ENZO Biochem Reports Strong Fiscal Fourth Quarter Results Transformative Programs to Heighten Efficiency, Broaden Capabilities Yield Solid Benefits |
Tuesday, October 07, 2014 | ENZO Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus Infections & Genetic Diseases |
Monday, October 06, 2014 | ENZO Biochem Schedules Teleconference to Discuss Fourth Quarter Results Friday, October 10, 2014 at 8:30 Am E.T. |
Thursday, July 31, 2014 | Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins ENZO Biochem’s Clinical Division |
Tuesday, July 29, 2014 | Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies |
Monday, June 30, 2014 | Enzo Biochem Added to Russell 2000 and Russell 3000 Indexes |
Monday, June 23, 2014 | ENZO Biochem Announces Settlement Agreement With Perkinelmer |
Monday, June 09, 2014 | ENZO Biochem Reports Strong Third Fiscal Quarter Results |
Friday, June 06, 2014 | ENZO Biochem Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy |
Tuesday, June 03, 2014 | ENZO Biochem Schedule's Teleconference To Discuss Third Quarter Results Tuesday, June 10, 2014 AT 8:30 AM E.T. |
Friday, May 30, 2014 | ENZO Biochem Unit Partners With Innate PHARMA S.A. To Validate Key System For Antibody Drug Conjugate Development ProteoStat® Dye to be Used in Early Phase Cancer Drug Design |
Friday, May 30, 2014 | ENZO Biochem Announces Appointment Of James M. O’Brien As Senior VP, Finance |
Thursday, May 29, 2014 | ENZO Biochem To Present At The Jeffries 2014 Global Healthcare Conference |
Thursday, April 24, 2014 | ENZO Biochem Announces Settlement Agreement With Affymetrix |
Tuesday, March 11, 2014 | ENZO Biochem Reports Across The Board Second Quarter 2014 Improved Results |
Monday, March 10, 2014 | ENZO Biochem Schedules Teleconference To Discuss Second Quarter Results Wednesday, March 12, 2014 AT 8:30 AM E.T. |
Tuesday, February 18, 2014 | ENZO Biochem’s Clinical Lab And NUCLEA Biotechnologies Join To Market New Test For Certain High Risk Breast Cancer Patients |
Tuesday, January 07, 2014 | Enzo Biochem Announces Upcoming Litigation Schedule |
Monday, January 06, 2014 | Federal Court Awards Enzo Biochem Over $61 Million in Patent Infringement Damages Judge Increases Jury Award by $12.4 Million in Prejudgment Interest |